B cells in Sjögren's syndrome: From pathophysiology to therapeutic target

35Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Biological abnormalities associated with B lymphocytes are a hallmark of patients with primary Sjögren's syndrome. Those patients present abnormal distribution of B lymphocytes in peripheral blood and B cells in exocrine glands. B cells produce auto-antibodies, cytokines and present antigens but can also suppressive functions. In this review, we will summarize current knowledge on B cells in primary Sjögren's syndrome patients, demonstrate their critical role in the immunopathology of the disease and describe the past and current trials targeting B cells.

Cite

CITATION STYLE

APA

Mielle, J., Tison, A., Cornec, Di., Le Pottier, L., Daien, C., & Pers, J. O. (2021, June 1). B cells in Sjögren’s syndrome: From pathophysiology to therapeutic target. Rheumatology (United Kingdom). Oxford University Press. https://doi.org/10.1093/rheumatology/key332

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free